Relationship of Biochemical Outcome to Percentage of Positive Biopsies in Men with Clinically Localized Prostate Cancer Treated with Permanent Interstitial Brachytherapy-Reference-Cited by-同舟云学术

Relationship of Biochemical Outcome to Percentage of Positive Biopsies in Men with Clinically Localized Prostate Cancer Treated with Permanent Interstitial Brachytherapy

Published:2008-04 Issue:4 Volume:71 Page:723-727
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Guzzo Thomas J.,Levin Brian M.,Lee Richard,Guo Mengye,Chen Zhen,Whittington Richard,Tomaszewski John,Malkowicz S. Bruce

Publisher

Elsevier BV

Subject

Urology

Reference17 articles.

1. Evidence to support a continued stage migration and decrease in prostate cancer specific mortality;Galper;J Urol,2006

2. More favorable tumor features and progression-free survival rates in a longitudinal prostate cancer screening study: PSA era and threshold-specific effects;Jang;Urology,2006

3. Migration in clinical and pathological stage of prostatic carcinoma in patients undergoing radical prostatectomy in the period between 1993 and 2003;Zebic;Coll Anthropol,2005

4. Improved prostate cancer-specific survival and other disease parameters: impact of prostate-specific antigen testing;Paquette;Urology,2002

5. Monotherapeutic brachytherapy for clinically organ-confined prostate cancer;Merrick;WV Med J,2005

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eligibility criteria according to EAU/ESTRO/SIOG guidelines for exclusive iodine-125 brachytherapy for intermediate-risk prostate adenocarcinoma patients: impact on relapse-free survival;Journal of Contemporary Brachytherapy;2021

2. Tumor burden and location as prognostic factors in patients treated by iodine seed implant brachytherapy for localized prostate cancers;Radiation Oncology;2019-12-31

3. Évaluation par questionnaire des pratiques de la curiethérapie de prostate en France;Progrès en Urologie;2017-10

4. Feasibility of brachytherapy as monotherapy for high-volume, low-risk prostate cancer;Journal of Cancer Research and Therapeutics;2016

5. Recommandations en onco-urologie 2013 du CCAFU : Cancer de la prostate;Progrès en Urologie;2013-11